V014-6564 Screening compound: N-[2-(4-methoxyphenyl)ethyl]-2-(4-{[(4-methylphenyl)carbamoyl]amino}piperidin-1-yl)benzamide

V014-6564 Screening compound: N-[2-(4-methoxyphenyl)ethyl]-2-(4-{[(4-methylphenyl)carbamoyl]amino}piperidin-1-yl)benzamide
V014-6564 Screening compound: N-[2-(4-methoxyphenyl)ethyl]-2-(4-{[(4-methylphenyl)carbamoyl]amino}piperidin-1-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-6564
N-[2-(4-methoxyphenyl)ethyl]-2-(4-{[(4-methylphenyl)carbamoyl]amino}piperidin-1-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-6564

Molecular Formula

C29H34N4O3 (C29 H34 N4 O3)

Compound Name

N-[2-(4-methoxyphenyl)ethyl]-2-(4-{[(4-methylphenyl)carbamoyl]amino}piperidin-1-yl)benzamide

IUPAC name

N-[2-(4-methoxyphenyl)ethyl]-2-(4-{[(4-methylphenyl)carbamoyl]amino}piperidin-1-yl)benzamide

SMILES

Cc(cc1)ccc1NC(NC(CC1)CCN1c(cccc1)c1C(NCCc(cc1)ccc1OC)=O)=O

InChI

InChI=1S/C29H34N4O3/c1-21-7-11-23(12-8-21)31-29(35)32-24-16-19-33(20-17-24)27-6-4-3-5-26(27)28(34)30-18-15-22-9-13-25(36-2)14-10-22/h3-14,24H,15-20H2,1-2H3,(H,30,34)(H2,31,32,35)

InChI Key

AUSIOPWRBYFANW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19894835

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

486.61

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.883

Distribution Coefficient, logD

4.883

Water Solubility, LogSw

-4.53

Polar Surface Area

68.347

Acid Dissociation Constant (pKa)

12.78

Base Dissociation Constant (pKb)

0.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

V014-6564 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V014-6564 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-6564?
Check Price and Availability of V014-6564, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-6564 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-6564
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-6564
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-6564 available by request